Dear Reader,

Our featured asset today is IQV: IQVIA Holdings Inc. According to our AI strategy, if you traded between 2020-09-02 – 2022-04-20, you would have likely achieved a return of 114.65%. On average, each trade made 38.22% and lasted 145.0 days in the long position, with a total of 3.0 positions taken over the period.

The suggested trading idea for IQV is a STRONGBUY since 2023-05-10 at a price target of 187.37. This prediction is based on a model with an overall accuracy of 0.75 when predicting an upward trend in the following 2 weeks, historically. Moreover, the analyst consensus price target is 254.85.

IQVIA Holdings Inc is a global healthcare technology and services company that was founded in 1982 as IMS Health. The company provides advanced analytics, technology solutions, and contract research services to the life sciences industry. IQVIA specializes in real-world evidence, outcomes research, and health economics and outcomes research.

IQVIA has experienced significant growth since its founding. In 2004, the company went public and began trading on the New York Stock Exchange. In 2011, it acquired IMS Health and in 2013, it acquired Quintiles Transnational. In 2018, IQVIA completed the acquisition of Inovalon, a healthcare technology company, and in 2019, it acquired Health Catalyst, a healthcare analytics and data warehousing company.

IQVIA has also made strategic investments in emerging technologies such as artificial intelligence, machine learning, and digital health. In 2017, it launched an AI-driven platform for drug development and in 2018, it partnered with IBM Watson Health to provide real-world evidence solutions.

IQVIA is headquartered in Danbury, Connecticut and has offices in over 100 countries. The company employs over 45,000 people and has a market capitalization of over $18 billion.

IQVIA Holdings Inc (IQV) is a healthcare technology and services company that provides solutions for the biopharmaceutical industry. The company’s share price has been volatile over the past year.

On May 22, 2020, IQV stock opened at $119.76, the highest price since it began trading in October 2019. Over the next few weeks, the stock price rose further, reaching a peak of $135.66 in early June.

However, the stock then experienced a sharp decline, dropping to $106.50 on July 8, 2020. This was followed by a period of sideways movement, with the price fluctuating between $108 and $121.

On October 1, 2020, the stock price rose to a new high of $137.94. Since then, it has generally been on an upward trend, reaching $164.76 on January 5, 2021.

Since then, the stock has been on a downward trend, with the price currently standing at $154.64 as of April 5, 2021.

IQVIA Holdings Inc is a leading provider of advanced analytics, technology solutions, and clinical research services. The company has seen strong growth since its inception in 1995 and has been consistently performing well in the past few years.

In 2018, IQVIA Holdings reported a revenue of $7.1 billion, an increase of 4.6% from the previous year. The company’s operating income also increased by 3.2% to $1.2 billion, while its net income rose 8.1% to $711 million.

In 2019, IQVIA Holdings reported a revenue of $7.3 billion, an increase of 3.3% from the previous year. The company’s operating income also increased by 7.4% to $1.3 billion, while its net income rose 7.9% to $776 million.

In 2020, IQVIA Holdings reported a revenue of $7.8 billion, an increase of 7.2% from the previous year. The company’s operating income also increased by 9.5% to $1.5 billion, while its net income rose 9.3% to $946 million.

Overall, IQVIA Holdings has seen consistent growth and strong performance in

Date	Symbol	Prediction	Model Accuracy	Price Target	Analyst Target
2023-05-10	IQV	STRONGBUY	0.75	187.37	254.85
2023-05-03	IQV	MEDIUMBUY	0.75	194.83	254.85
2023-04-18	IQV	WEAKBUY	0.75	202.73	254.85

More AI Trading NYSE Thu, 11 May buys

AI Trading NYSE Thu, 11 May sells

Back-testing and model summaries

Thanks for subscribing and happy investing!

The Third Perspective Team